With Stop Vivisection we have reached over 1.200.000 certified (legally recognized) signatures from the National Authorities ! We thus have become one of the only 3 successful ECIs presented in the first two years of implementation in Europe of the “Right of initiative” (application of art.11 of the European Treaty)- Such a great success forces… Read more
An open letter to Dr Harpal Kumar Dr Harpal Kumar MA MEng MBA DSc CEO of Cancer Research UK Cancer Research UK Angel Building 407 St John Street London EC1V 4AD 25 August, 2014. The role of Cancer Research UK and public accountability Dear Dr Kumar, Further to my open letter dated 20January 2014 and… Read more
We respectfully ask that you take into consideration the weight of the following moral, scientific, pedagogical and legal arguments against continuing this practice. The moral argument Civil society is willing to accept some forms of animal suffering, where the “end justifies the means” and on the understanding that the higher the cost to the animal… Read more
Many medical charities who rely for their funding on the goodwill of the general public go on to use this money to support animal research in the mistaken belief that animal experiments will yield data that is relevant to human disease. In his letter to CRUK, Andre Menache presents scientific data to show that animal models are… Read more
There are many ways in which animals are used in science, but their role as models for predicting human outcome is especially controversial. Read ‘Are animal models predictive for humans?’ by Niall Shanks, Ray Greek and Jean Greek, originally published in Philosophy, Ethics, and Humanities in Medicine.
The optimum time to get a new drug on to the market from its discovery to its sale is 12 years, at a cost of around 500 million euros. The clinical (in human) phase of drug development is by far the most expensive part of the entire process, accounting for 80% of the total cost,… Read more